Article Versions Notes

Taya Y, Mizunaga M, Nakao S, Jutanom M, Shimizu N, Nomura Y, Nakagawa K. Clinical Evaluation Based on a New Approach to Improve the Accuracy of 4β-Hydroxycholesterol Measurement as a Biomarker of CYP3A4 Activity. Molecules. 2023; 28(4):1576. https://doi.org/10.3390/molecules28041576

Taya, Yuki, Mari Mizunaga, Shunsuke Nakao, Mirinthorn Jutanom, Naoki Shimizu, Yukihiro Nomura, and Kiyotaka Nakagawa. 2023. "Clinical Evaluation Based on a New Approach to Improve the Accuracy of 4β-Hydroxycholesterol Measurement as a Biomarker of CYP3A4 Activity" Molecules 28, no. 4: 1576. https://doi.org/10.3390/molecules28041576

Taya, Y., Mizunaga, M., Nakao, S., Jutanom, M., Shimizu, N., Nomura, Y., & Nakagawa, K. (2023). Clinical Evaluation Based on a New Approach to Improve the Accuracy of 4β-Hydroxycholesterol Measurement as a Biomarker of CYP3A4 Activity. Molecules, 28(4), 1576. https://doi.org/10.3390/molecules28041576